The AJMC® Asthma compendium is a comprehensive resource for clinical news and expert insights for the chronic lung disease.
December 17th 2025
Twice-yearly depemokimab cuts asthma exacerbations in phase 3 trials for patients aged 12 and older with severe eosinophilic asthma.
Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care
1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health
View More
Updated Guidance and Managed Care Strategies to Optimize Respiratory Syncytial Virus Vaccination Coverage
1.5 Credits / Immunization, Infectious Disease, Pulmonology
View More
Reflecting on the Real-World Use of Biologic Therapy in Asthma Management
1.5 Credits / Immunology, Pulmonology
View More
Advancing Cystic Fibrosis Management: The Evolving Role of Specialty and Managed Care Pharmacists
1.5 Credits / Pulmonology
View More
Pulmonary Arterial Hypertension: Real-World Applications of New Therapies and Management Strategies
1.5 Credits / Pulmonology, Cardiology, Rare Diseases
View More
Updated Guidance and Managed Care Strategies to Optimize Care in EGFR Mutated NSCLC
2.0 Credits / Lung Cancer, Oncology, Pulmonology/Respiratory
View More
Payment for Pharmacist Services: 2025 Update
1.0 Credit / General Pharmacy, Health Equity, Diversity & Inclusion, Law
View More
An American Journal of Managed Care Forum: Bridging Evidence and Access in Advanced Small Cell Lung Cancer
1.5 Credit / Lung Cancer, Oncology, Pulmonology
View More
Study Highlights Uneven Symptom Burden in Patients With Uncontrolled vs Controlled Severe Asthma
July 10th 2023An analysis found that patients with uncontrolled severe asthma have a higher symptom burden compared with those whose severe asthma is controlled, highlighting the need for more innovative treatment options to improve asthma control.
Read More
Signs of Depression Linked to mAb Therapy Nonresponse in Patients With Severe Asthma
June 23rd 2023A recent study found that depressive symptoms improved among patients with severe asthma who responded to monoclonal antibody (mAb) therapy, but baseline depression symptoms were associated with lower therapy response rates.
Read More
Rates of Chronic Conditions, Asthma in Prisons May Be Severely Undertreated, Study Finds
April 27th 2023The study examined the prevalence of prescription medications in jails and state prisons for individuals with chronic conditions, such as asthma, type 2 diabetes, hypertension, hepatitis B and C, HIV infection, depression, and severe mental illness, compared with the general population.
Read More